Mark Smithers
Overview
Explore the profile of Mark Smithers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson M, Winter N, Smithers M
ANZ J Surg
. 2022 Sep;
92(9):1972-1973.
PMID: 36097423
No abstract available.
2.
Nilsson M, Olafsdottir H, Alexandersson von Dobeln G, Villegas F, Gagliardi G, Hellstrom M, et al.
Front Oncol
. 2022 Aug;
12:917961.
PMID: 35912196
Background: The globally dominant treatment with curative intent for locally advanced esophageal squamous cell carcinoma (ESCC) is neoadjuvant chemoradiotherapy (nCRT) with subsequent esophagectomy. This multimodal treatment leads to around 60%...
3.
Naik A, Smithers M, Moisander P
Appl Environ Microbiol
. 2021 Dec;
88(4):e0229821.
PMID: 34936837
Marine biofilms are diverse microbial communities and important ecological habitats forming on surfaces submerged in the ocean. Biofilm communities resist environmental disturbance, making them a nuisance to some human activities...
4.
DJourno X, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen M, Gisbertz S, et al.
JAMA Surg
. 2021 Jun;
156(9):836-845.
PMID: 34160587
Importance: Ninety-day mortality rates after esophagectomy are an indicator of the quality of surgical oncologic management. Accurate risk prediction based on large data sets may aid patients and surgeons in...
5.
Chen B, Jovanovic Z, Abel S, Le P, Halisdemir U, Smithers M, et al.
ACS Appl Mater Interfaces
. 2020 Aug;
12(38):42925-42932.
PMID: 32842731
To benefit from the diverse functionalities of perovskite oxides in silicon-based complementary metal oxide semiconductor (CMOS) technology, integrating oxides into a silicon platform has become one of the major tasks...
6.
Tie E, Lai-Kwon J, Rtshiladze M, Na L, Bozzi J, Read T, et al.
J Immunother Cancer
. 2020 May;
8(1).
PMID: 32376722
Background: The efficacy of immune checkpoint inhibitors (ICI) in metastatic melanoma is well established. However, there are limited data regarding their efficacy in in-transit melanoma (ITM). This study assessed the...
7.
Landi M, Bishop D, Macgregor S, Machiela M, Stratigos A, Ghiorzo P, et al.
Nat Genet
. 2020 Apr;
52(5):494-504.
PMID: 32341527
Most genetic susceptibility to cutaneous melanoma remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 cases of melanoma (67% newly genotyped) and 375,188 controls identified 54 significant (P ...
8.
Cebon J, Gore M, Thompson J, Davis I, McArthur G, Walpole E, et al.
J Immunother Cancer
. 2020 Apr;
8(1).
PMID: 32317292
Background: To compare the clinical efficacy of New York Esophageal squamous cell carcinoma-1 (NY-ESO-1) vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in a randomized, double-blind phase II study in participants...
9.
Gronchi A, Bonvalot S, Velasco A, Kotasek D, Rutkowski P, Hohenberger P, et al.
JAMA Surg
. 2020 Apr;
155(6):e200397.
PMID: 32236507
Importance: The association between quality of surgery and overall survival in patients affected by localized gastrointestinal stromal tumors (GIST) is not completely understood. Objective: To assess the risk of death...
10.
Di Bella C, Lee J, Koh C, Mukherjee P, Smithers M
ANZ J Surg
. 2020 Mar;
90(3):200-201.
PMID: 32147911
No abstract available.